240 related articles for article (PubMed ID: 14961154)
21. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
[TBL] [Abstract][Full Text] [Related]
22. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
24. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
25. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
Kannan M; Saxena R; Adiguzel C; Fareed J
Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
[TBL] [Abstract][Full Text] [Related]
26. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
Amiral J
Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
29. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
[TBL] [Abstract][Full Text] [Related]
30. Significance of quantitative measurement of heparin-induced platelet antibodies.
Javela K; Kekomäki R; Koskinen S
Eur J Haematol; 2010 Feb; 84(2):169-74. PubMed ID: 19845741
[TBL] [Abstract][Full Text] [Related]
31. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Williams RT; Damaraju LV; Mascelli MA; Barnathan ES; Califf RM; Simoons ML; Deliargyris EN; Sane DC
Circulation; 2003 May; 107(18):2307-12. PubMed ID: 12707235
[TBL] [Abstract][Full Text] [Related]
32. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
Alberio L
Curr Opin Hematol; 2008 Sep; 15(5):456-64. PubMed ID: 18695368
[TBL] [Abstract][Full Text] [Related]
33. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
34. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
35. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates.
Khairy M; Lasne D; Brohard-Bohn B; Aiach M; Rendu F; Bachelot-Loza C
Thromb Haemost; 2001 Jun; 85(6):1090-6. PubMed ID: 11434690
[TBL] [Abstract][Full Text] [Related]
36. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
Janatpour KA; Gosselin RC; Dager WE; Lee A; Owings JT; Zhou J; Wun T
Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
[TBL] [Abstract][Full Text] [Related]
38. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
39. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
Francis JL
Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
[TBL] [Abstract][Full Text] [Related]
40. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]